Results 121 to 130 of about 44,587 (167)

Chronic coronary syndrome and new-onset atrial fibrillation or venous thromboembolism: how best to manage antithrombotic therapy strategies. [PDF]

Eur Heart J Cardiovasc Pharmacother
Rubboli A, Angiolillo DJ, Becattini C, Lip GYH.   +3 more
europepmc   +1 more source

Fibrinography and thrombography (thrombodynamics-4D) in atrial fibrillation assessment of direct oral anticoagulants in geriatrics patients aged 80 years and older receiving direct oral anticoagulant therapy. [PDF]

Res Pract Thromb Haemost
Foulon-Pinto G, Jourdi G, Delrue M, Lafuente-Lafuente C, Cavalie C, Gouin-Thibault I, Le Guen J, Gaussem P, Mirault T, Puymirat E, Lecompte T, Pautas E, Curis E, Siguret V.   +13 more
europepmc   +1 more source

Heparin resistance in a patient with severe acute pancreatitis: a case report. [PDF]

Lab Med
Rongqin D, Zhexin B, Yuzhi L, Zhenbin G, Jinbiao Z.   +4 more
europepmc   +1 more source

Rebound warfarin toxicity presenting with spontaneous hemopericardium in cardiac tamponade: a case report. [PDF]

Int J Emerg Med
Rinzin U, Gurung M.
europepmc   +1 more source

Selective targeting of coagulation factor X Gla domain by negatively charged gold nanoparticles: a novel method for controlled antithrombotic therapy. [PDF]

Mater Today Bio
Li S, Yin Y, Hou D, Jin Y, Zhao Y, Tong J, Liu X, Shen G, Yue T, Liu K, Gu Y, Chen L, Ren F, Huang J, Tie JK, Hao Z.   +15 more
europepmc   +1 more source

Comparative clinical outcomes of acenocoumarol versus direct oral anticoagulants (DOACs) and warfarin in patients with atrial fibrillation: real-world-evidence (SIESTA-A study). [PDF]

Front Pharmacol
Montero-Balosa MC, Limón-Mora JA, Leal-Atienza A, García-Robredo B, Sánchez-Villegas P, Isabel-Gómez R, Aguado-Romeo MJ, Luque Romero LG, Molina-López MT.   +8 more
europepmc   +1 more source

Association of Genetic Variants With Rivaroxaban Pharmacokinetics and Pharmacodynamics and Hemorrhage Risk Factors in Patients With Venous Thromboembolism. [PDF]

J Am Heart Assoc
Li H, He X, Guan Y, Lu Q, Fang J, Bian X.   +5 more
europepmc   +1 more source

Apixaban- and Rivaroxaban-Associated Bleeding: A Retrospective Analysis Using the FDA Adverse Event Reporting System. [PDF]

Cureus
Logvinsky IK, Sanchez C, Ciuciureanu C, Wu E, El Aryan O, Delibasic M.   +5 more
europepmc   +1 more source

An Updated Meta-Analysis of Randomized Controlled Trials Comparing Direct Oral Anticoagulants Against Warfarin for Left Ventricular Thrombus Resolution. [PDF]

J Clin Med
Magdy J, He M, Arockiam S, Harada N, Wheatcroft SB, Bulluck H.   +5 more
europepmc   +1 more source

Effectiveness and safety of direct oral anticoagulants versus vitamin K antagonists in atrial fibrillation patients with liver disease: a systematic review and meta-analysis. [PDF]

Front Pharmacol
Zhou Q, Liu X, Liu S, Gu Z, Wu Y, Yang Y, Tao Y, Wei M.   +7 more
europepmc   +1 more source